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Research
It is well known that substantial risks of 
 leuke mia are associated with exposure to high 
acute doses of ionizing radiation [United 
Nations Scientific Committee on the Effects 
of Atomic Radiation (UNSCEAR 2008)]. 
Risks of leuke mia associated with pro-
tracted exposures to low doses of radiation, 
which occur among occupationally exposed 
nuclear industry workers (Cardis et al. 2007; 
Muirhead et al. 2009) or among the general 
public living in areas affected by accidental 
releases of radioactive materials (Krestinina 
et al. 2010), have been reported to be of 
similar magnitude, but several questions 
remain (Jacob et al. 2009; Richardson 2009; 
UNSCEAR 2010). Of special concern are 
radiation-related leuke mia risks among those 
who are engaged in emergency and recovery 
work after nuclear facility accidents because 
the level of exposure can be relatively high. As 
of 2006, over 500,000 persons from Belarus, 
the Russian Federation, and Ukraine had 
been registered as emergency and recovery 
workers after the 1986 Chornobyl accident 
(UNSCEAR 2011).
Although most types of leuke mia are 
known to be radiogenic (Little et al. 1999; 
Preston et al. 1994), to date very few studies 
have provided substantial evidence for a radio-
genic excess of chronic lymphocytic leuke mia 
(CLL) (UNSCEAR 2008). However, the view 
that CLL is not caused by radiation has been 
questioned (Linet et al. 2007; Richardson 
et al. 2005), and more recent studies based on 
incident rather than mortality outcomes have 
suggested a radiation effect on CLL as well as 
on other types of leuke mia (Kesminiene et al. 
2008; Lane et al. 2010; Mohner et al. 2010; 
Rericha et al. 2006; Romanenko et al. 2008b).
In our previous study of leuke mia occurring 
between 1986 and 2000 among Chornobyl 
cleanup workers from Ukraine (Romanenko 
et al. 2008b), we found a significantly increased 
risk of leuke mia,  similar in magnitude to the 
estimate from the Japanese atomic bomb sur-
vivors (UNSCEAR 2008). The data indicated 
elevated risks for both CLL and other leuke-
mias. We therefore extended the study through 
2006, with a near doubling of the number of 
leuke mia cases. We herein report results of the 
analy sis of the extended data.
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Background: Risks of most types of leuke mia from exposure to acute high doses of ionizing  radiation 
are well known, but risks associated with protracted exposures, as well as associations between radia-
tion and chronic lymphocytic leuke mia (CLL), are not clear.
oBjectives: We estimated relative risks of CLL and non-CLL from protracted exposures to low-
dose ionizing radiation.
Methods: A nested case–control study was conducted in a cohort of 110,645 Ukrainian cleanup 
workers of the 1986 Chornobyl nuclear power plant accident. Cases of incident leuke mia diagnosed 
in 1986–2006 were confirmed by a panel of expert hematologists/hematopathologists. Controls were 
matched to cases on place of resi dence and year of birth. We estimated individual bone marrow radia-
tion doses by the Realistic Analytical Dose Reconstruction with Uncertainty Estimation (RADRUE) 
method. We then used a conditional logistic regression model to estimate excess relative risk of leuke-
mia per gray (ERR/Gy) of radiation dose.
results: We found a significant linear dose response for all leuke mia [137 cases, ERR/Gy = 1.26 
(95% CI: 0.03, 3.58]. There were nonsignificant positive dose responses for both CLL and non-
CLL (ERR/Gy = 0.76 and 1.87, respectively). In our primary analy sis excluding 20 cases with 
direct in-person interviews < 2 years from start of chemo therapy with an anomalous finding of 
ERR/Gy = –0.47 (95% CI: < –0.47, 1.02), the ERR/Gy for the remaining 117 cases was 2.38 (95% 
CI: 0.49, 5.87). For CLL, the ERR/Gy was 2.58 (95% CI: 0.02, 8.43), and for non-CLL, ERR/Gy 
was 2.21 (95% CI: 0.05, 7.61). Altogether, 16% of leuke mia cases (18% of CLL, 15% of non-CLL) 
were attributed to radiation exposure.
conclusions: Exposure to low doses and to low dose-rates of radiation from post-Chornobyl 
cleanup work was associated with a significant increase in risk of leuke mia, which was statistically 
consistent with estimates for the Japanese atomic bomb survivors. Based on the primary analy sis, 
we conclude that CLL and non-CLL are both radiosensitive.
key words: Chernobyl nuclear accident, Chornobyl, Ukraine, chronic lymphocytic leuke mia, 
leuke mia, matched case–control study, radiation, radiation dose–response relationship, radiation-
induced leuke mia. Environ Health Perspect 121:59–65 (2013). http://dx.doi.org/10.1289/
ehp.1204996 [Online 8 November 2012]
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Methods
Study data. Data were from a nested case–
control study in a cohort of 110,645 male 
Ukrainian workers who were 20–60 years of 
age during cleanup activities in 1986–1990 
after the Chornobyl nuclear power plant 
accident and who were registered in the 
Chornobyl State Registry of Ukraine (SRU) 
before 1992 and resided in Kyiv City or in 
any one of five study oblasts (areas similar 
to a state or province: Cherkasy, Chernihiv, 
Dnipropetrovsk, Kharkiv, and Kyiv) at the 
time of registration (Romanenko et al. 2008a).
Potential cases for the period of 1986–
2000 were identified among persons diag-
nosed with leuke mia or with a diagnosis from 
a broad screening list of 99 ancillary condi-
tions that might possibly represent cases of 
leuke mia (including myelo dysplasia, non-
Hodgkin lymphoma, and multiple myeloma) 
at all health care institutions in the study 
area; potential cases were then used to create 
a Provisional Leukemia Registry (Romanenko 
et al. 2008a). Potential cases during 2001–
2006 were identified by linkage of the SRU 
cohort with the Ukrainian Cancer Registry 
(UCR), which achieved nationwide coverage 
in 1997 (Fedorenko et al. 2011).
A total of 162 cases of leuke mia were con-
firmed by the International Hematology Panel 
of five hematologists/hematopathologists. 
Most cases were confirmed unanimously after 
initial review of the cytological material and 
medical records or, lacking such initial una-
nimity, by a mutually acceptable consensus 
diagnosis after reexamination of all materials 
and in-depth discussion between the panel 
members. Descriptions of the clinical courses 
and histological confirmation of the diagno-
ses from the medical records were available 
for all cases. Bone marrow aspirates/biopsy 
slides and/or peripheral blood smears were 
available for 113 cases (70%). Acute leuke mia 
types were classified using the World Health 
Organization system of classification (Jaffe 
et al. 2001). CLL diagnoses were based on 
the criteria established by the U.S. National 
Cancer Institute (NCI) Working Group 
(Cheson et al. 1996). The diagnostic confirma-
tion rate for CLL (89%) and non-CLL cases 
(79%) did not differ significantly (p = 0.103).
With a targeted 5:1 control:case ratio, we 
used incidence–density sampling to randomly 
select 5–9 controls for each potential case from 
members of the cohort who were alive and 
at risk at the time of the case diagnosis and 
were matched to the case on place of resi dence 
(in one of five oblasts or Kyiv City) and year 
of birth, regardless of whether the potential 
control was alive at the time of ascertainment. 
Among 1,364 selected controls, 901 were inter-
viewed, 215 refused to participate, 213 could 
not be traced, and 35 moved out of the study 
regions. Response rates, including untraceable 
subjects, were 70% for live controls, 49% for 
next-of-kin, and 64% for colleagues respond-
ing for deceased controls. There were 677 
controls interviewed for 137 confirmed and 
interviewed leuke mia cases. In addition, 224 
controls were interviewed for cases that were 
not subsequently interviewed (directly or by 
proxy) or not confirmed. We rematched 186 
of the latter controls to confirmed cases using 
the matching criteria, resulting in a total of 863 
controls. We used all 863 controls in the analy-
ses because results with and without the extra 
controls were similar (data not shown).
A time-and-motion dose reconstruction 
method, known as Realistic Analytical Dose 
Reconstruction with Uncertainty Estimation 
(RADRUE), was developed specifically for 
this study and for a similar study conducted 
in Belarus, Russia, and Baltic countries 
(Kesminiene et al. 2008) by an inter national 
group of scientists including experts from 
Belarus, France, Russia, the United States, 
and Ukraine (Chumak et al. 2008; Kryuchkov 
et al. 2009). The method used combined data 
on work history from dosimetric question-
naires with field radioactivity measurements to 
estimate individual bone marrow doses for all 
study subjects. In-person interviews were con-
ducted by trained interviewers and included 
questions concerning locations of work and 
resi dence while in the 30-km exclusion zone 
around the Chornobyl nuclear power plant, 
types of work, transportation routes, and corre-
sponding dates. For deceased cases or controls, 
proxy interviews were conducted with next-of-
kin for demographic and medical information 
and with co-workers for work histories in the 
30-km exclusion zone. Proxy interviews were 
conducted for 69 deceased cases (38 non-CLL 
and 31 CLL, 50% of all cases) and 43 deceased 
controls (5% of all controls).
Radiation dose estimates were not avail-
able for 25 cases (15%): 2 were ineligible, 
17 could not be traced, 4 refused to complete 
the dosimetry questionnaire, and 2 had poor 
quality of interview response. Response rates 
were 96% for live cases and 79% for next-of-
kin and colleagues responding for deceased 
cases. The present study thus included 
137 confirmed cases with radiation dose esti-
mates, 79 CLL and 58 non-CLL cases [6 with 
acute lymphocytic leuke mia, 16 with acute 
myeloid leuke mia, 7 with acute leuke mia/
not otherwise specified, 24 chronic myeloid 
leuke mia, and 5 with other chronic leuke-
mia (2 large granular lymphocyte leuke mia–
natural killer cell type, and 3 large granular 
lymphocyte leuke mia–T-cell type)].
The protocol for the study was approved 
by the institutional review boards of the NCI 
(Bethesda, MD, USA); the University of 
California, San Francisco, School of Medicine 
(San Francisco, CA, USA); and the National 
Research Center for Radiation Medicine 
(Kyiv, Ukraine). All participants gave written 
informed consent.
Statistical analy sis. As in our previous 
study (Romanenko et al. 2008b), we fitted 
a conditional logistic regression model that 
assumed a linear dose–response relationship 
although we evaluated several alternative 
forms, including linear–quadratic, exponential, 
and power models. The model was fitted by 
maximum likeli hood (McCullagh and Nelder 
1989) using the EPICURE statistical package 
(Preston et al. 1993). The excess relative risk 
per gray (ERR/Gy) computed by this model 
is an estimate of the excess risk associated with 
exposure to 1 Gy relative to no radiation expo-
sure. We also estimated relative risks (RRs) 
for radiation dose categories. Using likeli hood 
ratio tests, we examined the potential modifi-
cations of association between radiation and 
the disease outcomes by means of interaction 
terms between radiation dose (continuous) and 
indicator terms for categorical variables (leuke-
mia subtype, proxy status, 0–1 vs. 2–15 years 
from start of chemo therapy to direct interview, 
and type of work performed in the 30-km 
Chornobyl zone) or continuous variables 
(year of case diagnosis, time since first expo-
sure, and age at first exposure), although for 
ease of presentation, the ERR/Gy estimates are 
shown for categories of continuous variables. 
The population- attributable risks (PARs) of all 
leuke mia, CLL, and non-CLL were estimated 
as the reduction in the leuke mia risk after elim-
ination of radiation exposure as a fraction of 
the total leuke mia risk:
PAR = ∑k Pk × (RRk – 1)/∑k Pk × RRk, [1]
where k = 0, 1, … , 100, and Pk and RRk are 
the proportion and model-based estimates of 
RR at the kth percentile dose level. For these 
computations, we approximated the bone 
marrow dose distribution by using percentiles. 
Confidence limits for PAR were based on the 
substitution method (Daly 1998).
Our analy ses were based on the cumula-
tive doses derived as the sums of the arithmetic 
means of the annual 1986–1990 bone marrow 
doses estimated by generating 10,000 realiza-
tions of dose predictions from the RADRUE 
method (Chumak et al. 2008). We assessed 
lag interval, a period of recent exposure 
assumed unrelated to disease, for the calcula-
tion of cumulative dose from 1986 to 1990 
in 1-year increments between 0 and 10 years. 
The deviance, a measure of model fit, was 
minimized for both CLL and non-CLL analy-
ses when we set the lag interval to either 1 or 
2 years [see Supplemental Material, Table S1 
(http://dx.doi.org/10.1289/ehp.1204996)], 
although the deviances were very similar for 
up to a lag of 5 years. When 20 cases who were 
interviewed < 2 years from start of chemo-
therapy were excluded, the optimal lag both 
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for CLL and non-CLL was 2 years. Choice 
of lag had little effect on the risk estimates 
(results not shown). Since various other bod-
ies (Committee to Assess Health Risks from 
Exposure to Low Levels of Ionizing Radiation 
2006; UNSCEAR 2008) recommend a lag of 
2 years for non-CLL, we lagged radiation doses 
by 2 years in all analy ses.
Tests of all hypotheses were based on 
likeli hood ratio tests. All tests were two-sided 
with a specified type I error of 0.05 and con-
fidence intervals (CIs) for risk estimates were 
derived by the profile likeli hood method 
(McCullagh and Nelder 1989). If the likeli-
hood being sought for a lower bound estimate 
did not converge, it was given by < –1/Dmax, 
where Dmax was the maximum radiation dose.
Results
The age at diagnosis of 137 cases ranged from 
25 to 78 years (median, 56) and the corre-
sponding age for 863 controls ranged from 
25 to 79 years (median, 55). Mean ± SD esti-
mated bone marrow radiation doses for cases 
and controls were 132.3 ± 342.6 mGy and 
81.8 ± 193.7 mGy, respectively (Table 1). 
Seventy-eight percent of study participants 
had bone marrow doses < 100 mGy, and 87% 
< 200 mGy. Cases and controls did not dif-
fer significantly by urban versus rural residen-
tial status at the time of interview, age at first 
radiation exposure in the 30-km Chornobyl 
zone, or education; however, more cases than 
controls were proxy-interviewed (p < 0.001) 
(Table 1). Cases and controls did not differ sig-
nificantly by calendar year of first cleanup mis-
sion, type of work or total number of missions, 
or by self-reported smoking, alcohol consump-
tion, medical or diagnostic radiation exposures, 
or occupational exposures to chemicals or 
radiation before and after the Chornobyl acci-
dent (results not shown). Thirty-eight percent 
of cleanup workers were in the 30-km zone 
around the Chornobyl nuclear power plant for 
> 2 months (median time in the zone for all 
workers, 35 days; range, 1–1,711 days; similar 
for cases and controls, p Wilcoxon = 0.729).
For all leuke mias, we found a significant 
positive association with continuous radiation 
dose with an estimated ERR/Gy = 1.26 (95% 
CI: 0.03, 3.58, p = 0.041) (Table 2). However, 
preliminary analy sis identified a significant 
(p = 0.021) difference in the dose response 
for 20 cases (6 non-CLL and 14 CLL) with 
direct in-person interviews < 2 years from start 
of chemo therapy compared with other cases 
[ERR/Gy = –0.47 (95% CI: < –0.47, 1.02, 
p = 0.244) for 20 cases vs. ERR/Gy = 2.38 
(95% CI: 0.49, 5.87, p = 0.004) for the 
remaining 117 cases] [Table 2 and also see 
Supplemental Material, Table S2, (http://
dx.doi.org/10.1289/ehp.1204996)]. Because 
of this marked disparity, we limited our pri-
mary analy ses to cases who were interviewed 
Table 1. Descriptive characteristics [n (%)] of cases and controls identified during follow-up (1986–2006).
Characteristic Cases (n = 137) Controls (n = 863) p-Valuea
Radiation dose, mGy [mean ± SD (range)]b 132.3 ± 342.6 (0–3220.0) 81.8 ± 193.7 (0–2600.0) 0.119c
Year of birth 0.988
1923–1929 10 (7) 67 (8)  
1930–1939 38 (28) 222 (26)  
1940–1949 43 (31) 285 (33)  
1950–1959 37 (27) 234 (27)  
1960–1965 9 (7) 55 (6)  
Areas of study 0.938
Cherkasy Oblast 7 (5) 60 (7)  
Chernihiv Oblast 11 (8) 77 (9)  
Dnipropetrovsk Oblast 26 (19) 155 (18)  
Kharkiv Oblast 17 (12) 107 (12)  
Kyiv Oblast 27 (20) 183 (21)  
Kyiv City 49 (36) 281 (33)  
Type of resi dence at time of interview 0.090
Urban 101 (74) 680 (79)  
Rural 19 (14) 151 (18)  
Other 10 (7) 32 (4)  
Unknown 7 (5) 0 (0)  
Age at first exposure (years) 0.970
20–34 31 (23) 207 (24)  
35–41 36 (26) 221 (26)  
42–49 40 (29) 239 (28)  
50–63 30 (22) 196 (23)  
Education 0.474
≤ 8 years 16 (12) 131 (15)  
High school 46 (34) 341 (40)  
Trade school 34 (25) 200 (23)  
College 34 (25) 188 (22)  
Unknown 7 (5) 3 (0)  
Proxy interviews  < 0.001
No 68 (50) 820 (95)  
Yes 69 (50) 43 (5)  
ap-Value from the chi-square test unless otherwise stated. bBone marrow radiation dose lagged by 2 years. cp-Value 
from the Wilcoxon rank sum test.
Table 2. ERR/Gy (95% CIs) for leuke mia within categories of various factors. 
Model description Cases (n) ERR/Gy (95% CI) p-Valuea p Interactionb
All cases 137 1.26 (0.03, 3.58) 0.041
Excluding cases with direct interviews 
< 2 years from start of chemo therapy
117 2.38 (0.49, 5.87) 0.004
Leukemia subtype
Non-CLL 52 2.21 (0.05, 7.61) 0.039 0.888
CLL 65 2.58 (0.02, 8.43) 0.047
Proxy statusc
Proxy 69 3.98 (< –0.15, 25.23) 0.420
Direct interview 48 0.88 (< –0.38, 5.28)
Year of case diagnosis
1986–1994 33 6.70 (0.27, 27.10)  0.141d
1995–2000 36 2.69 (–0.04, 11.23)
2001–2006 48 1.25 (< –0.69, 5.35)
Type of work performed in the 30-km Chornobyl zone
Early responders 32 1.49 (–0.02, 5.07) 0.711
Military personnel 43 4.23 (0.12, 12.59)  
Professional nuclear power workers 5 2.72 (< –0.91, 19.58)  
Other 37 4.23 (–0.27, 15.25)  
Time since first exposure (years)
≤ 9 38 5.10 (–0.02, 19.17)  0.162d
10–14 34 4.09 (0.39, 13.47)
15–20 45 0.84 (< –0.78, 4.50)
Age at first exposure (years)
20–34 27 1.01 (< –0.98, 8.65) 0.249d
35–41 30 1.61 (–0.49, 8.80)
42–49 33 5.67 (0.58, 21.79)
50–63 27 2.00 (< –0.38, 10.11)   
Cases with direct interviews < 2 years from start of chemo therapy are excluded from all analy ses except the “all cases” 
analy sis. 
ap-Value of departure of ERR/Gy from zero. bp-Value for interaction effects. cBackground rate adjusted for proxy status. 
dp-Value from the linear trend test.
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2–15 years after start of chemo therapy, did not 
have chemo therapy, or for whom proxy inter-
views were used and their matched controls 
(85% of all cases and 83% of all controls).
RRs increased with increasing radia-
tion dose for all leuke mia (Figure 1). Tests 
for quadratic, exponential, or power devia-
tions from the linear dose response shown 
in Figure 1 were not significant (p = 0.927, 
p = 0.917, p = 0.267, respectively). The dose 
responses increased significantly for both non-
CLL [ERR/Gy = 2.21 (95% CI: 0.05, 7.61, 
p = 0.039)] and CLL [ERR/Gy = 2.58 (95% 
CI: 0.02, 8.43, p = 0.047)] subtypes, with tests 
for interaction consistent with homogeneity 
(p = 0.888)] (Table 2).
We found no significant difference in 
ERR/Gy estimates by proxy or direct inter-
views (p = 0.420), calendar period of diagnosis 
(p = 0.141), or type of work performed in the 
30-km Chornobyl zone (p = 0.711) (Table 2). 
Although also not significant, ERR/Gy esti-
mates tended to decrease with increasing time 
(years) from first radiation exposure in the 
Chornobyl zone and to increase with increas-
ing age at first exposure (p = 0.162, p = 0.249, 
respectively) (Table 2). The proportion of 
proxy versus direct interviews decreased over 
time (60.0%, 73.9%, 55.6%, and 54.2% for 
cases diagnosed in 1986–1989, 1990–1994, 
1995–2000, and 2001–2006, respectively).
We estimated that approximately 16% of 
all leuke mia cases in our Chornobyl cleanup 
worker population over a period of 20 years of 
follow-up [PAR = 16.4% (95% CI: 3.9, 32.6)] 
were attributable to radiation exposure from the 
Chornobyl accident. The majority of the PAR 
arose from dose groups of < 200 mGy in which 
there were large numbers of cleanup workers 
(Figure 2). Proportions of CLL and non-CLL 
cases attributable to radiation were similar, with 
PARs of 17.5% (95% CI: 0.2, 41.0) and 15.4% 
(95% CI: 0.4, 38.5), respectively.
For completeness, we evaluated modifica-
tions of the ERR/Gy presented in Table 2 using 
all case and control data [see Supplemental 
Material, Table S2 (http://dx.doi.org/10.1289/
ehp.1204996)]. In general, results using the 
full dataset were consistent with the primary 
analy sis. However, the ERR/Gy for CLL [0.76 
(95% CI: < –0.38, 3.84, p = 0.352)] was lower 
than the estimated ERR/Gy for CLL from 
our primary analy sis excluding 14 CLL cases 
[2.58, (95% CI: 0.02, 8.43, p = 0.047)]. In the 
analy sis using the full dataset, as in the primary 
analy sis, the ERRs were not significantly dif-
ferent between CLL and non-CLL outcomes 
(p = 0.536).
Discussion
Here we report several important findings 
concerning the late effects of ionizing radia-
tion exposure. First, our results confirm and 
significantly strengthen the evidence from our 
previous study (Romanenko et al. 2008b) that 
showed significant associations between pro-
tracted radiation exposure at low doses and 
leuke mia incidence. Increased risks of leuke-
mia, although not statistically significant, 
were also reported from a study of Chornobyl 
cleanup workers from Belarus, Russia, and 
Baltic countries (Kesminiene et al. 2008). 
Second, our results indicate that radiation 
risk estimates are elevated for both CLL and 
non-CLL. Generally, assessment of radiation 
risks of cancer and leuke mia from exposures to 
low or protracted radiation doses derives from 
extrapolation of risks from epidemiological 
studies of populations exposed to single or high 
doses (e.g., studies of Japanese atomic bomb 
survivors and of medically exposed persons) 
(UNSCEAR 2008). It has been assumed 
that protraction of radiation dose results in 
a reduction of adverse biological effects, and 
an important uncertainty involved in these 
extrapolations relates to the risk associated 
with acute versus protracted exposure. The 
mean cumulative radiation doses (0.092 Gy) 
received by the Chornobyl cleanup work-
ers were lower than reported for the atomic 
bomb survivors (0.24 Gy) (UNSCEAR 2008), 
and the ERR/Gy estimate of 2.21 (95% CI: 
0.05, 7.61) for non-CLL was lower than the 
ERR/Gy of 3.98 (90% CI: 2.32, 6.45) for 
exposure at ≥ 40 years of age that can be esti-
mated from the atomic bomb survivor data, 
although the estimates are comparable given 
the range of statistical uncertainty.
Figure 1. RRs (95% CIs) of leuke mia by categories of radiation dose and fitted linear dose–response mod-
els. For display purposes, we added offsets to category mean doses on the abscissa coordinate to sepa-




















Figure 2. PARs of all leuke mia and CLL and non-CLL, separately.
Bone marrow dose (Gy)











CLL = 17.5% (0.2, 41.0)
All cases = 16.4% (3.9, 32.6)
Non-CLL = 15.4% (0.4, 38.5)
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Chornobyl cleanup workers had higher 
radiation doses than those reported in other 
studies of incident leuke mia after protracted 
radiation exposures, for example, the United 
Kingdom (mean = 0.025 Gy; Muirhead et al. 
2009) or Canadian (0.007 Sv; Sont et al. 
2001) radiation workers, Eldorado (0.052 Sv; 
Lane et al. 2010) or East German (0.024 Gy; 
Mohner et al. 2010) uranium miners, and the 
RRs of non-CLL leuke mia were generally com-
parable [ERR/Gy = 1.78 (90% CI: 0.17, 4.36) 
for UK and ERR/Gy = 2.7 (90% CI: < 0, 18.8) 
for Canadian radiation workers]. Radiation-
related risks of incident leuke mia in the cohort 
of Techa River residents exposed to radioactive 
releases from the Mayak nuclear facility were 
higher but statistically comparable to the risks 
estimated in our study [ERR/Gy = 4.9 (95% 
CI: 1.6, 14.3) (Krestinina et al. 2010)], pos-
sibly related to the fact that 92% of their bone 
marrow dose (mean = 0.30 Gy) was due to 
internal exposures to strontium.
We estimated similar radiation-related risks 
for CLL and non-CLL in our primary analy sis 
after excluding a subset of cases with inter-
views < 2 years from start of chemo therapy. 
The associations were attenuated when all cases 
were included in the analy sis, particularly for 
CLL, but the ERRs for CLL and non-CLL 
were not significantly different in either analy-
sis. The majority of epidemiological studies 
of radiation-exposed populations, whether 
from occupational or environmental exposures 
(Cardis et al. 2007; UNSCEAR 2008), or from 
therapeutic exposures (Boice et al. 1987; Curtis 
et al. 1994; Damber et al. 1995) have reported 
no excess of CLL. In reviewing the epidemio-
logy and etiology of CLL, Linet et al. (2007) 
and Richardson et al. (2005) stressed the need 
for special care to ascertain CLL cases, espe-
cially when relying on information from death 
certificates, because of the dormant charac-
teristics of this type of leuke mia. It is thus per-
tinent that the recently emerging evidence of 
a radiogenic etiology for CLL derives mainly 
from incidence studies. In particular, indica-
tions for increased risks of CLL from radiation 
exposure have come from incidence studies 
of Chornobyl cleanup workers from Belarus, 
Russia, and Baltic countries (Kesminiene et al. 
2008), and from uranium miners with expo-
sures to alpha particles and gamma radiation 
in Canada, Germany, and Czechoslovakia 
(Lane et al. 2010; Mohner et al. 2010; Rericha 
et al. 2006). On the other hand, radiation and 
CLL were not associated according to analy-
ses of incidence data in UK radiation workers 
(Muirhead et al. 2009) or the Techa River resi-
dents (Krestinina et al. 2010). The inconsistent 
results from studies of various exposed groups 
are puzzling, possibly implying diagnostic vari-
ability between the studies, and indicate the 
need for more intensive investigations in these 
and other irradiated populations.
While B cell–derived CLL may differ 
from other types of leuke mia in etiology and 
pathogenesis, there is biological plausibility 
for the radiogenic potential for CLL. Mature 
B-cell CLLs are clonal proliferations of B cells 
at various stages of differentiation, and the ini-
tiating genetic lesions can occur in immature 
bone marrow B cells (Chiorazzi et al. 2005). 
Recent studies reported marked similarities in 
somatic mutations of CLL and other leuke mias 
(Richardson et al. 2005). Also, it is possible 
that radiation may trigger the progression of 
benign monoclonal B-cell lympho cytosis, a 
putative precursor to CLL (Linet et al. 2007).
The strengths of this study include the large 
number of cases compared to studies of high- 
and moderate-dose exposures and of low-dose 
exposures among occupationally exposed work-
ers, the selection of cases and controls from 
within a large cohort of cleanup workers of the 
1986 Chornobyl nuclear power plant accident 
from Ukraine, the wide and rigorous search for 
diagnoses of leuke mia, and the confirmation of 
all diagnoses by a panel of hematologists and 
hematopathologists based on medical records 
that were available for all cases, and biological 
materials (including bone marrow aspirates/
biopsy slides and/or peripheral blood smears) 
that were available for 113 cases (70%). In 
particular, the diagnostic confirmation rates for 
CLL (89%) and non-CLL cases (79%) were 
high and comparable. In a study of cleanup 
workers from Belarus, Russia, and Baltic coun-
tries (Kesminiene et al. 2008), slides and case 
notes were available for review for 73% of 
cases, but 15% of the material submitted for 
review was judged to be inadequate for diag-
nosis. The interview participation rates in our 
study for both cases and controls as well as for 
alive subjects and proxies for deceased study 
subjects were reasonable. To minimize poten-
tial biases, interviewers were not aware of case–
control status and were carefully trained not 
to ask probing questions beyond those listed 
on the questionnaire. Similarly, doses were 
estimated without knowledge of case–control 
status and members of the hematology panel 
did not know the radiation dose of cases under 
review. Finally, the information collected dur-
ing interviews allowed us to estimate the effects 
of a number of potential confounders not 
generally available in other studies of cleanup 
workers (Ivanov 2007).
As in many retrospective case–control stud-
ies, recall bias can lead to biased estimation of 
radiation doses and is a concern in the present 
study. However, repeat interviews of alive sub-
jects suggested good recall of missions within 
the Chornobyl cleanup zone (Kryuchkov 
et al. 2009). Fifty percent of case informa-
tion was provided by proxy interviews. Mean 
bone marrow doses for subjects with direct 
and proxy interviews were not significantly 
different (p Wilcoxon = 0.577 and 0.512 for 
cases and controls, respectively). ERR/Gy esti-
mates were higher, although not significantly 
so (p = 0.420), for proxy-interviewed than 
directly-interviewed subjects. Cleanup work-
ers generally worked in groups and performed 
similar work, with co-worker proxies having 
first-hand knowledge about cleanup activi-
ties of deceased workers. Comparison of data 
from proxy interviews of live subjects with 
that from the subjects themselves resulted in 
comparable radiation dose estimates averaged 
over 102 pairs of subjects and proxies (geo-
metric mean of the ratio of doses = 0.91), but 
large variabilities were suggested when ratios 
of doses for individual pairs of subjects and 
proxies were considered (Kryuchkov et al. 
2009). Participation rates were higher for alive 
cases than for alive controls. Kesminiene et al. 
(2008) reported generally similar findings, 
with participation rates for cases also tending 
to be somewhat greater than for controls at 
97% and 96%, respectively, for cleanup work-
ers from Belarus; 87% and 91%, respectively, 
from Russia; and 82% and 73%, respectively, 
from Baltic countries.
Case ascertainment procedures varied dur-
ing the study period of 1986–2006. As noted 
in the “Methods,” we identified cases using 
local health care facilities before 2001, whereas 
later cases were identified through the link-
age of the cohort file with the UCR files. We 
compared ascertainment methods by using 
both procedures in Kyiv City. Case identifi-
cation was identical, except for one recently 
diagnosed case that would have been reported 
to the UCR later in the year. In addition, we 
searched UCR files for cases diagnosed in 
1986–2000 in areas other than study areas 
and did not identify any new cases among 
cohort members.
We observed a significant increase in the 
risk of leuke mia with radiation dose based 
on the entire study sample. However, a pre-
liminary examination of differences in various 
characteristics of participating cases, ascertained 
using the two methods described above, indi-
cated that cases with direct in- person interviews 
< 2 years from start of chemo therapy treatment 
had mean bone marrow radiation dose esti-
mates significantly lower than other cases inter-
viewed in-person (16.8 vs. 121.4 mGy, 7-fold 
difference in means, p Wilcoxon = 0.036), and 
these doses were uniformly lower across all 
types of work performed in the 30-km zone, 
whereas the mean doses for controls from both 
groups were almost identical. The ERR/Gy esti-
mates for cases with direct interviews < 2 years 
from start of chemo therapy (ERR/Gy = –0.47) 
and the remaining cases (ERR/Gy = 2.38) dif-
fered significantly (p = 0.021), with the for-
mer estimate incompatible with our current 
understanding of radiation-related leuke mia 
risk. ERR/Gy estimates in the former group 
were negative overall and by time since first 
Zablotska et al.
64 volume 121 | number 1 | January 2013 • Environmental Health Perspectives
exposure, for cases diagnosed in 1986–2000 
and 2001–2006, and for CLL and non-CLL 
cases (data not shown). The discrepancy could 
have arisen by chance or from an unknown 
ascertainment anomaly. Other possible reasons 
were that the 20 cases were undergoing ther-
apy at the time of interview or were in poorer 
health compared to other cases, which could 
have influenced the accuracy of recall. In our 
primary analy ses, we omitted these 20 cases 
so that results were not unduly influenced. 
Nevertheless, patterns of results using all cases 
were generally similar. In the analy sis using all 
cases, the risks both for CLL and non-CLL 
were lower, particularly for CLL [0.76 (95% 
CI: < –0.38, 3.84, p = 0.352) vs. 2.58 (95% 
CI: 0.02, 8.43, p = 0.047)] [Table 2 and also 
see Supplemental Material, Table S2 (http://
dx.doi.org/10.1289/ehp.1204996)]. In other 
respects, in relation to the variation of risks 
by year of case diagnosis, type of work per-
formed, time since first exposure, or age at first 
exposure, the patterns were broadly similar (see 
Supplemental Material, Table S2). However, 
it must be recognized that our final results 
derived from a post hoc subgroup analy sis.
The mean radiation doses for cases ascer-
tained in 1986–2000 (Romanenko et al. 
2008b) and 2001–2006 after excluding cases 
with direct in-person interviews < 2 years 
from start of chemo therapy treatment, were 
similar (mean ± SD) (143.8 ± 408.8 mGy 
and 152.0 ± 286.8, respectively, p Wilcoxon 
= 0.616), and there was no statistically sig-
nificant difference in the dose response 
[ERR/Gy = 3.44 (95% CI: 0.47, 9.78) vs. 
ERR/Gy = 1.25 (95% CI: < –0.69, 5.35), 
p for interaction = 0.403, not shown]. Tests of 
linear trend for modifying effects of calendar 
year of diagnosis and years since first exposure 
were not statistically significant (p = 0.141 and 
p = 0.162, respectively, Table 2), but estimated 
radiation-related RRs of all leuke mia generally 
tended to decrease. The decreasing temporal 
trend may have, at least partially, been due 
to the higher ERR/Gy associated with proxy 
interviews, which were conducted with many 
of the leuke mia cases diagnosed in the early 
years after the accident.
The proportion of CLL cases in our study 
(58%) was higher than the approximately 
40% reported by most population-based can-
cer registries (Dores et al. 2007) and 44% 
of all diagnosed leuke mias among males in 
Ukraine (Gluzman et al. 2006). [Note that 
this number differs from the 29.32% reported 
in Gluzman et al. (2006), which was calculated 
as a proportion of CLL among all hematologi-
cal malignancies, including multiple myeloma 
and NHL.] An earlier study suggested that 
cancer registries may be missing as much as 
38% of CLL compared with the incidence of 
CLL detected using sophisticated measures 
such as flow cytometric immunophenotypic 
analy sis (Zent et al. 2001). Using the age-
 specific incidence rate of CLL among men in 
Ukraine for 2003, we estimated that the num-
ber of CLL cases diagnosed in our cohort of 
110,645 male cleanup workers over the period 
of 20 years after the accident was 60% higher 
than what would be expected for the general 
male population of Ukraine [standardized 
incidence ratio = 1.60 (95% CI: 1.3, 2.0)]. 
Although part of this increase could be due to 
estimated radiation effects of CLL, we specu-
late that performance of recommended annual 
medical examinations, including blood tests 
and a visit to a hematologist, for Chornobyl 
cleanup workers could have resulted in better 
case ascertainment and/or detection of cases 
at earlier stages than in a general population 
(Gluzman et al. 2006).
Conclusions
Our findings provide important evidence of 
increased risk of leuke mia associated with 
chronic protracted exposure to low doses 
of ionizing radiation. The finding from our 
primary analy sis of similar radiogenic risks both 
for CLL and non-CLL was based on a well-
defined population-based cohort, rigorous case 
ascertainment, and expert hematological review 
coupled with well-characterized radiation 
dose estimates. In our cohort of cleanup 
workers from 1986 through 2006, about 16% 
(19 cases) of all leuke mia were attributed to 
radiation exposure, with similar estimates for 
non-CLL (15%) and CLL (18%). CLL is the 
most common type of leuke mia in this cleanup 
worker population and, as the workers age, 
CLL cases will rapidly increase, raising concerns 
for medical consequences. The radiogenic 
risk for CLL also has important public health 
implications in other populations because 
it is the most prevalent type of leuke mia in 
Western populations, with approximately 
16,000 cases estimated to be diagnosed in the 
United States in 2012 (Howlader et al. 2012). 
Further investigations are needed to develop a 
better understanding of the association between 
radiation and CLL.
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